Dyne Net Interest Income from 2010 to 2026
| DYN Stock | USD 17.14 0.15 0.88% |
Net Interest Income | First Reported 2019-09-30 | Previous Quarter 6.5 M | Current Value 5.6 M | Quarterly Volatility 3 M |
Check Dyne Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dyne Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 M, Interest Expense of 2.5 M or Selling General Administrative of 74.6 M, as well as many indicators such as Price To Sales Ratio of 6.54, Dividend Yield of 0.0 or PTB Ratio of 3.36. Dyne financial statements analysis is a perfect complement when working with Dyne Therapeutics Valuation or Volatility modules.
Dyne | Net Interest Income | Build AI portfolio with Dyne Stock |
Evaluating Dyne Therapeutics's Net Interest Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Dyne Therapeutics's fundamental strength.
Latest Dyne Therapeutics' Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Dyne Therapeutics over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Dyne Therapeutics' Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dyne Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Dyne Net Interest Income Regression Statistics
| Arithmetic Mean | 5,957,448 | |
| Coefficient Of Variation | 196.76 | |
| Mean Deviation | 8,681,509 | |
| Median | 5,000 | |
| Standard Deviation | 11,721,604 | |
| Sample Variance | 137.4T | |
| Range | 32.8M | |
| R-Value | 0.73 | |
| Mean Square Error | 69.3T | |
| R-Squared | 0.53 | |
| Significance | 0.001 | |
| Slope | 1,685,796 | |
| Total Sum of Squares | 2198.3T |
Dyne Net Interest Income History
About Dyne Therapeutics Financial Statements
Dyne Therapeutics investors utilize fundamental indicators, such as Net Interest Income, to predict how Dyne Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 31 M | 32.5 M |
Pair Trading with Dyne Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dyne Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Dyne Stock
Moving against Dyne Stock
| 0.56 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.46 | ENGN | enGene Holdings Common | PairCorr |
| 0.35 | 63E | ONWARD MEDICAL BV | PairCorr |
The ability to find closely correlated positions to Dyne Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dyne Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dyne Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dyne Therapeutics to buy it.
The correlation of Dyne Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dyne Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dyne Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dyne Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Dyne Therapeutics Correlation against competitors. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Will Biotechnology sector continue expanding? Could Dyne diversify its offerings? Factors like these will boost the valuation of Dyne Therapeutics. Projected growth potential of Dyne fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Dyne Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Dyne Therapeutics is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dyne Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Dyne Therapeutics' market value can be influenced by many factors that don't directly affect Dyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Dyne Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Dyne Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Dyne Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.